The global market for HIV-1 therapeutics, which is the treatment for the Human Immunodeficiency Virus, reached a size of USD 27.3 billion in 2022 and is projected to reach USD 42.35 billion by 2032, with an expected annual revenue growth rate of 5% throughout the forecast period. This market expansion can be attributed to several key factors. One significant driver is the increasing prevalence...